invasive candidiasis

Candida spp. peritonitis (clinical cases, register analysis and literature review)

We present a case of fungal peritonitis in a patient secondary to intestinal perforation and repeated laparotomy. An analysis of data from the register of patients with invasive candidiasis is also presented. In the study were included 42 patients …

Prognostic rules for invasive candidiasis risk assessment in ICU patients

nvasive candidiasis is an extremely important problem for severe patients in intensive care units. The high rates of attributive mortality are associated not only with the severity of the patient’s condition, but also with a delayed therapy due to …

Review of the guidelines for the treatment and prevention of invasive candidiasis in newborns and children

nvasive infections caused by Candida species are the most common invasive fungal infections in children of different age groups. Premature neonates, especially newborns with low and extremely low birth-weight, have very high mortality rates, with the …

Pharmacoeconomic Analysis of Anidulafungin (Eraxis®) Use in the Treatment of Invasive Candidiasis

Invasive candidiasis is a common infectious complication in intensive care units and hematological malignancies chemotherapy units. This study presents data from the first-in-Russia health economics review of the anidulafungin use in the treatment of …

Pharmacoeconomic Analysis of Micafungin (Mycamin®) Use in the Treatment of Patients with Invasive Candidiasis

It was the first-in-Russia clinical and economic expertise of the micafungin (Mycamin) use in the treatment of adult patients with invasive candidiasis in intensive care units (ICUs). Using simulation methods, a total cost considering treatment …

Empiric Therapy of Invasive Candidiasis in Intensive Care Units: Current State of Problem

The high prevalence of invasive candidiasis (IC) in intensive care units (ICU) is one of the major problems of medical mycology and the modern medicine in general. More than 10% of all infections in ICU are caused by Candida spp. Infections caused by …

Clinical and Pharmacoeconomic Analysis of the Treatment of Invasive Candidiasis in Intensive Care Units

Invasive candidiasis is a third or fourth cause of sepsis in intensive care units (ICUs). Clinical and pharmacoeconomic study of treatment for invasive candidiasis was first performed using mathematical modeling in Russian economic environment. ICU …

Fungal Infections Surveillance in Intensive Care Units

Invasive candidiasis is a common nosocomial infection with high attributable mortality among ICU patients. This study was performed to determine isolation rate of Candida spp. in cardiac surgical ICUs during the period of 2001–2007 and to assess …

Clinical and Pharmacoeconomic Analysis of the Fluconazole Use for the Prophylaxis of Invasive Candidiasis in Very-Low-Birth Weight Infants

Very-low-birth weight preterm infants (<1500 g) are at high risk for invasive candidiasis. The prospective randomized controlled clinical trial comparing efficacy of 2 doses of fluconazole (3 and 6 mg/kg) in the prophylaxis of invasive candidiasis …

First Russian Experience of Successful Use of Caspofungin in Invasive Candidiasis in Patient with Severe Hepatic Failure (Clinical case)

A clinical case of the successful use of caspofungin for the treatment of invasive candidiasis, caused by fluconazole- and voriconazole-resistant strain of Candida glabrata, in the patient with severe hepatic failure (Child-Pugh score of 12) due to …